Calendrier des promotions Agenus Inc.
Calendrier avancé
Graphique simple
À propos de l'entreprise Agenus Inc.
Agenus Inc., иммуноонкологическая компания клинической стадии, открывает и разрабатывает иммуноонкологические продукты в США и за рубежом. Компания предлагает Retrocyte Display, платформу экспрессии антител для идентификации полностью человеческих и гуманизированных моноклональных антител; и дисплейные технологии. Компания разрабатывает адъювант QS-21 Stimulon, вакцинный адъювант на основе сапонинов. plus de détailsParamètres de base
IPO date
2000-02-04
ISIN
US00847G7051
Industry
Biotechnology
Sector
Health Care
Валюта
usd
Валюта отчета
usd
Сайт
Grade
Sous-estimation
| Nom | Signification | Grade |
| P/S | 0.5583 | 10 |
| P/BV | -0.1885 | 0 |
| P/E | 0 | 0 |
Efficacité
| Nom | Signification | Grade |
| ROA | -84.12 | 0 |
| ROE | 93.37 | 10 |
| ROIC | 0 | 0 |
Dividendes
| Nom | Signification | Grade |
| Rendement en dividendes | 0 | 0 |
| DSI | 0 | 0 |
| Croissance moyenne du dividende | 0 | 0 |
Devoir
| Nom | Signification | Grade |
| Debt/EBITDA | -0.9365 | 10 |
| Debt/Ratio | 0.4193 | 10 |
| Debt/Equity | -1.74 | 10 |
Impulsion de croissance
| Nom | Signification | Grade |
| Rentabilité Revenue, % | 17.34 | 3 |
| Rentabilité Ebitda, % | -8.48 | 0 |
| Rentabilité EPS, % | 887.43 | 10 |
paper.price.prices
| Prix | Common.min. | Common.max. | Changement | paper.changes_in_industry | paper.changes_in_index | |
| common.calendar.number_days.1 | 4.7 $ | 0 $ | 0 $ | 0 % | 0 % | 0 % |
| common.calendar.number_days.7d | 5.55 $ | 4.7 $ | 5.37 $ | -15.32 % | 0 % | 0 % |
| common.calendar.number_days.30d | 3.82 $ | 3.02 $ | 5.63 $ | 23.04 % | 0 % | 0 % |
| common.calendar.number_days.90d | 1.62 $ | 1.5 $ | 5.63 $ | 190.12 % | 0 % | 0 % |
| common.calendar.number_days.180d | 3.9 $ | 1.5 $ | 5.63 $ | 20.51 % | 0 % | 0 % |
| common.calendar.number_days.1y | 5.11 $ | 1.5 $ | 17.73 $ | -8.02 % | 0 % | 0 % |
| common.calendar.number_days.3y | 2.61 $ | 0.58 $ | 18.56 $ | 80.11 % | 0 % | 0 % |
| common.calendar.number_days.5y | 3.28 $ | 0.58 $ | 18.56 $ | 43.4 % | 0 % | 0 % |
| common.calendar.number_days.10y | 0 $ | 0.58 $ | 18.56 $ | 0 % | 0 % | 0 % |
| common.calendar.number_days.ytd | 3.51 $ | 1.5 $ | 5.63 $ | 33.9 % | 0 % | 0 % |
Entreprises similaires
P/E & P/BV
Gestion d'entreprise
| Superviseur | Titre d'emploi | Paiement | Année de naissance |
| Dr. Garo H. Armen Ph.D. | Founder, Executive Chairman & CEO | 1.34M | 1953 (72 année) |
| Ms. Christine M. Klaskin | VP of Finance, Principal Financial Officer & Principal Accounting Officer | 407.44k | 1966 (59 années) |
| Craig Winter | Chief Information Officer | N/A | |
| Mr. Zack Armen | Head of Investor Relations | N/A | |
| Ms. Tracy Mazza Clemente | Chief People Officer | N/A | |
| Mr. Alfred Dadson | Chief Manufacturing Officer | N/A | |
| Mr. Eric Humes | Chief Quality Officer | N/A | |
| Dr. Todd Jude Yancey M.D. | Member of Advisory Board & Chief Strategic Advisor | N/A | |
| Dr. Steven J. O'Day M.D., Ph.D. | Chief Medical Officer | 1961 (64 année) | |
| Dr. Robin G. Taylor M.B.A., Ph.D. | Chief Commercial Officer |
Informations sur l'entreprise
Adresse: United States, Lexington. MA -, 3 Forbes Road - Ouvrir dans google maps, Ouvrir les cartes yandex
Site web: https://www.agenusbio.com
Site web: https://www.agenusbio.com
